

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.66309207 |
| 2 | myelination (GO:0042552) | 6.72000366 |
| 3 | axon ensheathment (GO:0008366) | 6.71074116 |
| 4 | ensheathment of neurons (GO:0007272) | 6.71074116 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.77410091 |
| 6 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.33718464 |
| 7 | myelin maintenance (GO:0043217) | 4.87495424 |
| 8 | negative regulation of neurotransmitter transport (GO:0051589) | 4.81960573 |
| 9 | cholesterol biosynthetic process (GO:0006695) | 4.64757654 |
| 10 | oligodendrocyte differentiation (GO:0048709) | 4.43677310 |
| 11 | apical protein localization (GO:0045176) | 4.13102898 |
| 12 | sterol biosynthetic process (GO:0016126) | 4.06666593 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.05825288 |
| 14 | negative regulation of protein localization to cell surface (GO:2000009) | 4.05065478 |
| 15 | asymmetric protein localization (GO:0008105) | 4.03895338 |
| 16 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.03168379 |
| 17 | establishment of mitochondrion localization (GO:0051654) | 4.02472154 |
| 18 | astrocyte development (GO:0014002) | 3.98553649 |
| 19 | photoreceptor cell differentiation (GO:0046530) | 3.96923593 |
| 20 | eye photoreceptor cell differentiation (GO:0001754) | 3.96923593 |
| 21 | presynaptic membrane assembly (GO:0097105) | 3.93630474 |
| 22 | regulation of collateral sprouting (GO:0048670) | 3.92052126 |
| 23 | creatine metabolic process (GO:0006600) | 3.87868856 |
| 24 | L-amino acid import (GO:0043092) | 3.86897956 |
| 25 | response to methylmercury (GO:0051597) | 3.85685557 |
| 26 | insulin secretion (GO:0030073) | 3.84404728 |
| 27 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.74567059 |
| 28 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.71156107 |
| 29 | response to redox state (GO:0051775) | 3.68717105 |
| 30 | astrocyte differentiation (GO:0048708) | 3.68322100 |
| 31 | amyloid precursor protein metabolic process (GO:0042982) | 3.66216950 |
| 32 | substantia nigra development (GO:0021762) | 3.65485399 |
| 33 | adhesion of symbiont to host cell (GO:0044650) | 3.59208200 |
| 34 | virion attachment to host cell (GO:0019062) | 3.59208200 |
| 35 | response to lipoprotein particle (GO:0055094) | 3.56851156 |
| 36 | import into cell (GO:0098657) | 3.55226994 |
| 37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.52522529 |
| 38 | peptide hormone processing (GO:0016486) | 3.52248776 |
| 39 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.52153150 |
| 40 | detection of calcium ion (GO:0005513) | 3.49648203 |
| 41 | isoprenoid biosynthetic process (GO:0008299) | 3.48963246 |
| 42 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.44848796 |
| 43 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.42226366 |
| 44 | myelination in peripheral nervous system (GO:0022011) | 3.40425037 |
| 45 | peripheral nervous system axon ensheathment (GO:0032292) | 3.40425037 |
| 46 | macroautophagy (GO:0016236) | 3.39819389 |
| 47 | regulation of extracellular matrix disassembly (GO:0010715) | 3.39685898 |
| 48 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.34562433 |
| 49 | glutamate secretion (GO:0014047) | 3.33671567 |
| 50 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.30472297 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.29640514 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.23796436 |
| 53 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.23655010 |
| 54 | protein palmitoylation (GO:0018345) | 3.20312853 |
| 55 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.19517383 |
| 56 | glycosylceramide metabolic process (GO:0006677) | 3.18927107 |
| 57 | adult walking behavior (GO:0007628) | 3.16367124 |
| 58 | positive regulation of action potential (GO:0045760) | 3.15211720 |
| 59 | neuron cell-cell adhesion (GO:0007158) | 3.14610123 |
| 60 | magnesium ion transport (GO:0015693) | 3.14037231 |
| 61 | very long-chain fatty acid metabolic process (GO:0000038) | 3.12062942 |
| 62 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.08599846 |
| 63 | nucleotide transmembrane transport (GO:1901679) | 3.07616628 |
| 64 | negative regulation of JUN kinase activity (GO:0043508) | 3.06716531 |
| 65 | membrane tubulation (GO:0097320) | 3.06568784 |
| 66 | axon development (GO:0061564) | 3.00418554 |
| 67 | neuronal action potential propagation (GO:0019227) | 2.98894554 |
| 68 | limb bud formation (GO:0060174) | 2.96569212 |
| 69 | synaptic vesicle maturation (GO:0016188) | 2.96564461 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 2.95702269 |
| 71 | negative regulation of axonogenesis (GO:0050771) | 2.93016550 |
| 72 | auditory receptor cell differentiation (GO:0042491) | 2.92818683 |
| 73 | proline transport (GO:0015824) | 2.92222835 |
| 74 | amino acid import (GO:0043090) | 2.91363750 |
| 75 | GPI anchor biosynthetic process (GO:0006506) | 2.90524892 |
| 76 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.90423516 |
| 77 | nerve growth factor signaling pathway (GO:0038180) | 2.89613775 |
| 78 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.89539857 |
| 79 | GPI anchor metabolic process (GO:0006505) | 2.89031385 |
| 80 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.86330787 |
| 81 | neuromuscular process controlling posture (GO:0050884) | 2.85802601 |
| 82 | inositol phosphate catabolic process (GO:0071545) | 2.85277633 |
| 83 | cellular response to epinephrine stimulus (GO:0071872) | 2.85188783 |
| 84 | regulation of lipoprotein metabolic process (GO:0050746) | 2.84417634 |
| 85 | peptide hormone secretion (GO:0030072) | 2.83644406 |
| 86 | positive regulation of neurotransmitter transport (GO:0051590) | 2.83584653 |
| 87 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.83437868 |
| 88 | ketone body metabolic process (GO:1902224) | 2.82579701 |
| 89 | amyloid precursor protein catabolic process (GO:0042987) | 2.82501150 |
| 90 | cellular potassium ion homeostasis (GO:0030007) | 2.80695452 |
| 91 | thioester biosynthetic process (GO:0035384) | 2.79924649 |
| 92 | acyl-CoA biosynthetic process (GO:0071616) | 2.79924649 |
| 93 | peptide secretion (GO:0002790) | 2.77248127 |
| 94 | negative regulation of complement activation (GO:0045916) | 2.76964983 |
| 95 | negative regulation of hormone metabolic process (GO:0032351) | 2.75318340 |
| 96 | endocrine pancreas development (GO:0031018) | 2.72945486 |
| 97 | positive regulation of insulin secretion (GO:0032024) | 2.72597312 |
| 98 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.71622755 |
| 99 | peripheral nervous system development (GO:0007422) | 2.70644704 |
| 100 | neuronal ion channel clustering (GO:0045161) | 2.70358714 |
| 101 | epithelial cell fate commitment (GO:0072148) | 2.70293817 |
| 102 | neuron remodeling (GO:0016322) | 2.70025223 |
| 103 | adhesion of symbiont to host (GO:0044406) | 2.68242841 |
| 104 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.65252430 |
| 105 | potassium ion homeostasis (GO:0055075) | 2.63567908 |
| 106 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.62495342 |
| 107 | response to epinephrine (GO:0071871) | 2.62307600 |
| 108 | toxin metabolic process (GO:0009404) | 2.61649922 |
| 109 | regulation of neurotransmitter uptake (GO:0051580) | 2.61417592 |
| 110 | peptidyl-cysteine modification (GO:0018198) | 2.60611558 |
| 111 | alanine transport (GO:0032328) | 2.59707183 |
| 112 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.57302062 |
| 113 | ear development (GO:0043583) | 2.56187562 |
| 114 | glial cell development (GO:0021782) | 2.54637782 |
| 115 | organ growth (GO:0035265) | 2.54626021 |
| 116 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.54271397 |
| 117 | inositol phosphate dephosphorylation (GO:0046855) | 2.54271397 |
| 118 | cerebellar granule cell differentiation (GO:0021707) | 2.53306422 |
| 119 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.52374209 |
| 120 | protein localization to endosome (GO:0036010) | 2.50694643 |
| 121 | cerebellar Purkinje cell layer development (GO:0021680) | 2.49870166 |
| 122 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.49494973 |
| 123 | positive regulation of glycolytic process (GO:0045821) | 2.49157631 |
| 124 | Golgi to endosome transport (GO:0006895) | 2.48861920 |
| 125 | iron coordination entity transport (GO:1901678) | 2.48536648 |
| 126 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.48401318 |
| 127 | positive regulation of glial cell differentiation (GO:0045687) | 2.47492560 |
| 128 | negative regulation of protein activation cascade (GO:2000258) | 2.47095918 |
| 129 | phospholipid dephosphorylation (GO:0046839) | 2.46267551 |
| 130 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.46200549 |
| 131 | membrane assembly (GO:0071709) | 2.45877682 |
| 132 | neurotransmitter secretion (GO:0007269) | 2.45490141 |
| 133 | negative regulation of inclusion body assembly (GO:0090084) | 2.45035539 |
| 134 | response to dietary excess (GO:0002021) | 2.44839899 |
| 135 | nitric oxide mediated signal transduction (GO:0007263) | 2.44490946 |
| 136 | cellular response to catecholamine stimulus (GO:0071870) | 2.43840961 |
| 137 | cellular response to monoamine stimulus (GO:0071868) | 2.43840961 |
| 138 | neurotransmitter catabolic process (GO:0042135) | 2.43353449 |
| 139 | regulation of catecholamine metabolic process (GO:0042069) | 2.42635854 |
| 140 | regulation of dopamine metabolic process (GO:0042053) | 2.42635854 |
| 141 | Golgi to plasma membrane protein transport (GO:0043001) | 2.42438714 |
| 142 | tonic smooth muscle contraction (GO:0014820) | 2.42164809 |
| 143 | locomotory exploration behavior (GO:0035641) | 2.41937012 |
| 144 | neural nucleus development (GO:0048857) | 2.41489730 |
| 145 | negative regulation of axon extension (GO:0030517) | 2.41227175 |
| 146 | glial cell differentiation (GO:0010001) | 2.41077439 |
| 147 | neurotransmitter uptake (GO:0001504) | 2.40322491 |
| 148 | heme transport (GO:0015886) | 2.39034643 |
| 149 | dopamine biosynthetic process (GO:0042416) | 2.36529648 |
| 150 | artery smooth muscle contraction (GO:0014824) | 2.36525839 |
| 151 | hormone secretion (GO:0046879) | 2.34741926 |
| 152 | L-serine transport (GO:0015825) | 2.34406967 |
| 153 | signal release (GO:0023061) | 2.34164649 |
| 154 | positive regulation of calcium ion import (GO:0090280) | 2.33702190 |
| 155 | response to gravity (GO:0009629) | 2.33512420 |
| 156 | type B pancreatic cell development (GO:0003323) | 2.32968492 |
| 157 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.32677728 |
| 158 | regulation of beta-amyloid formation (GO:1902003) | 2.32533389 |
| 159 | positive regulation of peptide hormone secretion (GO:0090277) | 2.32500003 |
| 160 | positive regulation of macroautophagy (GO:0016239) | 2.32132326 |
| 161 | positive regulation of peptide secretion (GO:0002793) | 2.31567046 |
| 162 | regulation of insulin secretion (GO:0050796) | 2.31244211 |
| 163 | positive regulation of protein autophosphorylation (GO:0031954) | 2.31032032 |
| 164 | regulation of Rac protein signal transduction (GO:0035020) | 2.30789335 |
| 165 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.29909883 |
| 166 | vascular smooth muscle contraction (GO:0014829) | 2.29265912 |
| 167 | peptide transport (GO:0015833) | 2.28858173 |
| 168 | regulation of execution phase of apoptosis (GO:1900117) | 2.25125169 |
| 169 | L-phenylalanine catabolic process (GO:0006559) | 2.24717156 |
| 170 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.24717156 |
| 171 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.23756901 |
| 172 | long-term synaptic potentiation (GO:0060291) | 2.21881358 |
| 173 | potassium ion import (GO:0010107) | 2.21145412 |
| 174 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.19008806 |
| 175 | positive regulation of gluconeogenesis (GO:0045722) | 2.18914762 |
| 176 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.18913155 |
| 177 | hormone transport (GO:0009914) | 2.18511630 |
| 178 | regulation of neurotransmitter transport (GO:0051588) | 2.18361661 |
| 179 | glycosphingolipid biosynthetic process (GO:0006688) | 2.18334514 |
| 180 | regulation of glucokinase activity (GO:0033131) | 2.17770550 |
| 181 | regulation of hexokinase activity (GO:1903299) | 2.17770550 |
| 182 | nitric oxide biosynthetic process (GO:0006809) | 2.17548694 |
| 183 | chemosensory behavior (GO:0007635) | 2.17210063 |
| 184 | retinol metabolic process (GO:0042572) | 2.15124692 |
| 185 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.14820524 |
| 186 | inositol phosphate-mediated signaling (GO:0048016) | 2.12774074 |
| 187 | axon ensheathment in central nervous system (GO:0032291) | 10.6135074 |
| 188 | central nervous system myelination (GO:0022010) | 10.6135074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61405139 |
| 2 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.62628616 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.38141677 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.30676732 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28108352 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.27616762 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.21053379 |
| 8 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.10153555 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.02166668 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01555019 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.97806514 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.97806514 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.96611497 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91957066 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91810027 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91488950 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90818007 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89928450 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.89113565 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.85292207 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82127845 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.78320796 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.77511260 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77302124 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.74641257 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.71270206 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70482220 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68353432 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.67248895 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65689501 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57676684 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.56862136 |
| 33 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54231957 |
| 34 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51988570 |
| 35 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51242403 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50855456 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50124582 |
| 38 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.49610909 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49390021 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47175681 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47140038 |
| 42 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.44173482 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41737882 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41235162 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40583843 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.35003448 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31112043 |
| 48 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30568617 |
| 49 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29673678 |
| 50 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28310578 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28141016 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27803613 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.27584843 |
| 54 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27070330 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26741319 |
| 56 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.26625786 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26545078 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25081220 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25081220 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24422005 |
| 61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24032193 |
| 62 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23779955 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23354374 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23211267 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22937999 |
| 66 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20699453 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19974964 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19544032 |
| 69 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.16817258 |
| 70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15617756 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15095355 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14530136 |
| 73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.14028059 |
| 74 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13841744 |
| 75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13129954 |
| 76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12449075 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12135725 |
| 78 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11770369 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.10327061 |
| 80 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.10011260 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09457302 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08902182 |
| 83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08687348 |
| 84 | CJUN_26792858_Chip-Seq_BT549_Human | 1.08641674 |
| 85 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08633098 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08078676 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05880784 |
| 88 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05640794 |
| 89 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05319966 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04904979 |
| 91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04733047 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03567620 |
| 93 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02119068 |
| 94 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02030531 |
| 95 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00842921 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00756862 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00397042 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00180412 |
| 99 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99647319 |
| 100 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99582040 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99295777 |
| 102 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99183421 |
| 103 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.98554326 |
| 104 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98303304 |
| 105 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97978387 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97666008 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97268128 |
| 108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.96955385 |
| 109 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96749193 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95627417 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95051169 |
| 112 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.95036258 |
| 113 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94241342 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94050064 |
| 115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93860536 |
| 116 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91778019 |
| 117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90309291 |
| 118 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 0.89634883 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89527937 |
| 120 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89306445 |
| 121 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89164636 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89164636 |
| 123 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89158204 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88972335 |
| 125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87917392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.33856951 |
| 2 | MP0003880_abnormal_central_pattern | 3.67240092 |
| 3 | MP0004270_analgesia | 3.35419689 |
| 4 | MP0003690_abnormal_glial_cell | 3.31016714 |
| 5 | MP0000013_abnormal_adipose_tissue | 3.28615937 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.18461349 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.89674904 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.88695549 |
| 9 | MP0005379_endocrine/exocrine_gland_phen | 2.73840663 |
| 10 | MP0004885_abnormal_endolymph | 2.70754551 |
| 11 | MP0003329_amyloid_beta_deposits | 2.69326771 |
| 12 | MP0002272_abnormal_nervous_system | 2.52419915 |
| 13 | MP0005171_absent_coat_pigmentation | 2.40289909 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.38499941 |
| 15 | MP0001905_abnormal_dopamine_level | 2.37862967 |
| 16 | MP0001529_abnormal_vocalization | 2.35137447 |
| 17 | MP0001486_abnormal_startle_reflex | 2.34948332 |
| 18 | MP0010386_abnormal_urinary_bladder | 2.34450891 |
| 19 | MP0003634_abnormal_glial_cell | 2.33663156 |
| 20 | MP0002064_seizures | 2.31213656 |
| 21 | MP0004742_abnormal_vestibular_system | 2.31120610 |
| 22 | MP0004142_abnormal_muscle_tone | 2.29312253 |
| 23 | MP0003136_yellow_coat_color | 2.19828698 |
| 24 | MP0004043_abnormal_pH_regulation | 2.17222968 |
| 25 | MP0003787_abnormal_imprinting | 2.05815202 |
| 26 | MP0001485_abnormal_pinna_reflex | 2.04529013 |
| 27 | MP0000778_abnormal_nervous_system | 1.98590942 |
| 28 | MP0003283_abnormal_digestive_organ | 1.97597665 |
| 29 | MP0001944_abnormal_pancreas_morphology | 1.94464010 |
| 30 | MP0002229_neurodegeneration | 1.92815744 |
| 31 | MP0009046_muscle_twitch | 1.90638106 |
| 32 | MP0003632_abnormal_nervous_system | 1.90348566 |
| 33 | MP0003122_maternal_imprinting | 1.82389733 |
| 34 | MP0003635_abnormal_synaptic_transmissio | 1.82313339 |
| 35 | MP0005409_darkened_coat_color | 1.80150352 |
| 36 | MP0009745_abnormal_behavioral_response | 1.77740525 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.75199129 |
| 38 | MP0005503_abnormal_tendon_morphology | 1.72453184 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.72099712 |
| 40 | MP0001958_emphysema | 1.71572078 |
| 41 | MP0002876_abnormal_thyroid_physiology | 1.69627610 |
| 42 | MP0001984_abnormal_olfaction | 1.68603812 |
| 43 | MP0000462_abnormal_digestive_system | 1.66609036 |
| 44 | MP0005410_abnormal_fertilization | 1.64119289 |
| 45 | MP0001756_abnormal_urination | 1.59164501 |
| 46 | MP0005423_abnormal_somatic_nervous | 1.58297650 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.49522006 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.48836283 |
| 49 | MP0003631_nervous_system_phenotype | 1.48496671 |
| 50 | MP0003195_calcinosis | 1.47445771 |
| 51 | MP0005551_abnormal_eye_electrophysiolog | 1.47325137 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.44653729 |
| 53 | MP0000955_abnormal_spinal_cord | 1.43410746 |
| 54 | MP0002693_abnormal_pancreas_physiology | 1.41747444 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.40935439 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.40790784 |
| 57 | MP0002254_reproductive_system_inflammat | 1.39782056 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.38485021 |
| 59 | MP0000604_amyloidosis | 1.37332919 |
| 60 | MP0005451_abnormal_body_composition | 1.36877043 |
| 61 | MP0003879_abnormal_hair_cell | 1.36764384 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.36705314 |
| 63 | MP0004134_abnormal_chest_morphology | 1.36272167 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.35822181 |
| 65 | MP0002139_abnormal_hepatobiliary_system | 1.33951809 |
| 66 | MP0001661_extended_life_span | 1.33206586 |
| 67 | MP0002063_abnormal_learning/memory/cond | 1.32722149 |
| 68 | MP0003633_abnormal_nervous_system | 1.32514295 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.31920725 |
| 70 | * MP0002882_abnormal_neuron_morphology | 1.29853922 |
| 71 | MP0002163_abnormal_gland_morphology | 1.29672179 |
| 72 | MP0009840_abnormal_foam_cell | 1.28220784 |
| 73 | MP0008569_lethality_at_weaning | 1.27974496 |
| 74 | MP0000383_abnormal_hair_follicle | 1.27423589 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.25703078 |
| 76 | MP0001346_abnormal_lacrimal_gland | 1.25137446 |
| 77 | MP0000566_synostosis | 1.24751668 |
| 78 | MP0002066_abnormal_motor_capabilities/c | 1.23086615 |
| 79 | MP0004147_increased_porphyrin_level | 1.21999310 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.21016632 |
| 81 | MP0001963_abnormal_hearing_physiology | 1.20827155 |
| 82 | MP0002067_abnormal_sensory_capabilities | 1.20295396 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.18961033 |
| 84 | MP0004924_abnormal_behavior | 1.18961033 |
| 85 | MP0003172_abnormal_lysosome_physiology | 1.18693396 |
| 86 | MP0003868_abnormal_feces_composition | 1.17754838 |
| 87 | MP0006054_spinal_hemorrhage | 1.17510010 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.16645846 |
| 89 | MP0002938_white_spotting | 1.16286506 |
| 90 | MP0004381_abnormal_hair_follicle | 1.12845705 |
| 91 | MP0001970_abnormal_pain_threshold | 1.11678137 |
| 92 | MP0000639_abnormal_adrenal_gland | 1.10703843 |
| 93 | MP0005448_abnormal_energy_balance | 1.09758746 |
| 94 | MP0005535_abnormal_body_temperature | 1.05662750 |
| 95 | MP0000747_muscle_weakness | 1.05414237 |
| 96 | MP0002971_abnormal_brown_adipose | 1.05116901 |
| 97 | MP0002752_abnormal_somatic_nervous | 1.04357433 |
| 98 | MP0003011_delayed_dark_adaptation | 0.98496941 |
| 99 | MP0001177_atelectasis | 0.98298220 |
| 100 | MP0002822_catalepsy | 0.98288586 |
| 101 | MP0005408_hypopigmentation | 0.96569576 |
| 102 | MP0003938_abnormal_ear_development | 0.93874335 |
| 103 | MP0008004_abnormal_stomach_pH | 0.92590444 |
| 104 | MP0005646_abnormal_pituitary_gland | 0.92560158 |
| 105 | MP0005195_abnormal_posterior_eye | 0.91590217 |
| 106 | MP0008877_abnormal_DNA_methylation | 0.90991813 |
| 107 | MP0005332_abnormal_amino_acid | 0.90828724 |
| 108 | MP0002295_abnormal_pulmonary_circulatio | 0.90690263 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.90468069 |
| 110 | MP0002733_abnormal_thermal_nociception | 0.89841486 |
| 111 | MP0001851_eye_inflammation | 0.88195613 |
| 112 | MP0003045_fibrosis | 0.87251126 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.86233948 |
| 114 | MP0000647_abnormal_sebaceous_gland | 0.85698747 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.85355137 |
| 116 | MP0004215_abnormal_myocardial_fiber | 0.84721063 |
| 117 | MP0004145_abnormal_muscle_electrophysio | 0.83012047 |
| 118 | MP0000427_abnormal_hair_cycle | 0.82460742 |
| 119 | MP0002118_abnormal_lipid_homeostasis | 0.82384424 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.82365767 |
| 121 | MP0003279_aneurysm | 0.81935774 |
| 122 | MP0005253_abnormal_eye_physiology | 0.81655635 |
| 123 | MP0005275_abnormal_skin_tensile | 0.80602649 |
| 124 | MP0003953_abnormal_hormone_level | 0.80224470 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.79753602 |
| 126 | MP0005623_abnormal_meninges_morphology | 0.79573667 |
| 127 | MP0005248_abnormal_Harderian_gland | 0.79057197 |
| 128 | MP0005365_abnormal_bile_salt | 0.77357106 |
| 129 | * MP0002152_abnormal_brain_morphology | 0.76340642 |
| 130 | MP0008260_abnormal_autophagy | 0.75459718 |
| 131 | MP0008438_abnormal_cutaneous_collagen | 0.75290910 |
| 132 | MP0001542_abnormal_bone_strength | 0.74735827 |
| 133 | MP0002735_abnormal_chemical_nociception | 0.74159287 |
| 134 | MP0001502_abnormal_circadian_rhythm | 0.73554556 |
| 135 | MP0000003_abnormal_adipose_tissue | 0.73411961 |
| 136 | MP0000026_abnormal_inner_ear | 0.73331096 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.72840156 |
| 138 | MP0002108_abnormal_muscle_morphology | 0.72293668 |
| 139 | MP0005645_abnormal_hypothalamus_physiol | 0.72287640 |
| 140 | MP0001968_abnormal_touch/_nociception | 0.72270995 |
| 141 | MP0000372_irregular_coat_pigmentation | 0.71092128 |
| 142 | MP0002090_abnormal_vision | 0.70546041 |
| 143 | MP0003937_abnormal_limbs/digits/tail_de | 0.70395523 |
| 144 | MP0000762_abnormal_tongue_morphology | 0.69979287 |
| 145 | MP0001501_abnormal_sleep_pattern | 0.69280564 |
| 146 | MP0000631_abnormal_neuroendocrine_gland | 0.68825415 |
| 147 | MP0000467_abnormal_esophagus_morphology | 0.68149006 |
| 148 | MP0002557_abnormal_social/conspecific_i | 0.66884540 |
| 149 | MP0002736_abnormal_nociception_after | 0.64544056 |
| 150 | MP0006082_CNS_inflammation | 0.64344421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.60534516 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.60534516 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.21497417 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 4.92878248 |
| 5 | Sensory axonal neuropathy (HP:0003390) | 4.75332989 |
| 6 | Parakeratosis (HP:0001036) | 4.54347878 |
| 7 | Cerebral inclusion bodies (HP:0100314) | 4.45100083 |
| 8 | Peripheral hypomyelination (HP:0007182) | 4.06292823 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 3.69934007 |
| 10 | Hyperglycemia (HP:0003074) | 3.66458171 |
| 11 | Hypoglycemic seizures (HP:0002173) | 3.59834829 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.57842026 |
| 13 | Spastic gait (HP:0002064) | 3.55328406 |
| 14 | Intention tremor (HP:0002080) | 3.54149230 |
| 15 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.48115013 |
| 16 | Cerebral hypomyelination (HP:0006808) | 3.44282729 |
| 17 | Onion bulb formation (HP:0003383) | 3.42313569 |
| 18 | Hemiparesis (HP:0001269) | 3.38342333 |
| 19 | Large for gestational age (HP:0001520) | 3.37278328 |
| 20 | Increased CSF protein (HP:0002922) | 3.34951495 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.20872393 |
| 22 | Termporal pattern (HP:0011008) | 3.19097691 |
| 23 | Insidious onset (HP:0003587) | 3.19097691 |
| 24 | Postural tremor (HP:0002174) | 3.18342214 |
| 25 | Dysmetria (HP:0001310) | 3.17747832 |
| 26 | Alacrima (HP:0000522) | 3.10744667 |
| 27 | Intestinal atresia (HP:0011100) | 3.06089900 |
| 28 | Enlarged penis (HP:0000040) | 3.05736543 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.03820709 |
| 30 | Abnormal auditory evoked potentials (HP:0006958) | 3.01135806 |
| 31 | Anteriorly placed anus (HP:0001545) | 2.98544194 |
| 32 | Scanning speech (HP:0002168) | 2.98498523 |
| 33 | Abnormality of glycolysis (HP:0004366) | 2.96232543 |
| 34 | Increased serum pyruvate (HP:0003542) | 2.96232543 |
| 35 | Double outlet right ventricle (HP:0001719) | 2.92999575 |
| 36 | Congenital malformation of the right heart (HP:0011723) | 2.92999575 |
| 37 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.92708904 |
| 38 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.89899951 |
| 39 | Akinesia (HP:0002304) | 2.89827406 |
| 40 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.85167768 |
| 41 | Ketoacidosis (HP:0001993) | 2.84710923 |
| 42 | Increased circulating renin level (HP:0000848) | 2.83082365 |
| 43 | Leukodystrophy (HP:0002415) | 2.77355958 |
| 44 | Retinal dysplasia (HP:0007973) | 2.69753794 |
| 45 | Buphthalmos (HP:0000557) | 2.69468792 |
| 46 | Torticollis (HP:0000473) | 2.68147179 |
| 47 | Pheochromocytoma (HP:0002666) | 2.64801692 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.64107274 |
| 49 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.63505208 |
| 50 | Abnormal eating behavior (HP:0100738) | 2.60424097 |
| 51 | Metabolic alkalosis (HP:0200114) | 2.55793694 |
| 52 | Myokymia (HP:0002411) | 2.55308726 |
| 53 | Premature skin wrinkling (HP:0100678) | 2.55282627 |
| 54 | Thickened helices (HP:0000391) | 2.55272918 |
| 55 | Ankle clonus (HP:0011448) | 2.53738140 |
| 56 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.50857212 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.50857212 |
| 58 | Cerebral hemorrhage (HP:0001342) | 2.49154283 |
| 59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44186453 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44186453 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44186453 |
| 62 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.43182915 |
| 63 | Abnormality of vitamin metabolism (HP:0100508) | 2.43121022 |
| 64 | Hypokalemic alkalosis (HP:0001949) | 2.40861461 |
| 65 | Decreased lacrimation (HP:0000633) | 2.39647380 |
| 66 | Stridor (HP:0010307) | 2.39293094 |
| 67 | Polyphagia (HP:0002591) | 2.39162312 |
| 68 | Proximal tubulopathy (HP:0000114) | 2.36021619 |
| 69 | Hypothermia (HP:0002045) | 2.34463513 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.34119529 |
| 71 | Autoamputation (HP:0001218) | 2.33908657 |
| 72 | Spastic paraparesis (HP:0002313) | 2.33400979 |
| 73 | Hypoplastic pelvis (HP:0008839) | 2.32909631 |
| 74 | Split foot (HP:0001839) | 2.32253039 |
| 75 | Epileptiform EEG discharges (HP:0011182) | 2.31803752 |
| 76 | Focal dystonia (HP:0004373) | 2.31565733 |
| 77 | Congenital sensorineural hearing impairment (HP:0008527) | 2.30806257 |
| 78 | Hypomagnesemia (HP:0002917) | 2.29382109 |
| 79 | Abnormality of vitamin B metabolism (HP:0004340) | 2.29131681 |
| 80 | Clumsiness (HP:0002312) | 2.28424743 |
| 81 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27848491 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.26599211 |
| 83 | Hyperphosphatemia (HP:0002905) | 2.26422248 |
| 84 | Absent septum pellucidum (HP:0001331) | 2.25504649 |
| 85 | Vascular calcification (HP:0004934) | 2.25459727 |
| 86 | Symptomatic seizures (HP:0011145) | 2.22535423 |
| 87 | Aqueductal stenosis (HP:0002410) | 2.21544700 |
| 88 | Metaphyseal dysplasia (HP:0100255) | 2.19914443 |
| 89 | Hypokinesia (HP:0002375) | 2.19506114 |
| 90 | CNS hypomyelination (HP:0003429) | 2.19492369 |
| 91 | Methylmalonic acidemia (HP:0002912) | 2.19296277 |
| 92 | Aplasia of the phalanges of the hand (HP:0009802) | 2.18506908 |
| 93 | Aplasia involving bones of the extremities (HP:0009825) | 2.18506908 |
| 94 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.18506908 |
| 95 | Megalencephaly (HP:0001355) | 2.12260512 |
| 96 | Abnormality of dentin (HP:0010299) | 2.11208104 |
| 97 | Lower limb muscle weakness (HP:0007340) | 2.11149253 |
| 98 | Nuclear cataract (HP:0100018) | 2.10978244 |
| 99 | Craniofacial dystonia (HP:0012179) | 2.07602838 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.07404060 |
| 101 | Heterochromia iridis (HP:0001100) | 2.07156455 |
| 102 | Agitation (HP:0000713) | 2.07099422 |
| 103 | Synostosis involving the elbow (HP:0003938) | 2.06515314 |
| 104 | Humeroradial synostosis (HP:0003041) | 2.06515314 |
| 105 | Anxiety (HP:0000739) | 2.03423992 |
| 106 | Febrile seizures (HP:0002373) | 2.03032063 |
| 107 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.02834113 |
| 108 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.02834113 |
| 109 | Broad metatarsal (HP:0001783) | 2.02509629 |
| 110 | Action tremor (HP:0002345) | 2.02341438 |
| 111 | Coronal craniosynostosis (HP:0004440) | 2.01963776 |
| 112 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.01718769 |
| 113 | Mitral stenosis (HP:0001718) | 1.99802536 |
| 114 | Infantile muscular hypotonia (HP:0008947) | 1.99051028 |
| 115 | White forelock (HP:0002211) | 1.98490943 |
| 116 | Testicular neoplasm (HP:0010788) | 1.97215607 |
| 117 | Urinary incontinence (HP:0000020) | 1.96547513 |
| 118 | Patchy hypopigmentation of hair (HP:0011365) | 1.96442269 |
| 119 | Cupped ear (HP:0000378) | 1.94971602 |
| 120 | Protrusio acetabuli (HP:0003179) | 1.93721505 |
| 121 | Hypsarrhythmia (HP:0002521) | 1.93402501 |
| 122 | Gaze-evoked nystagmus (HP:0000640) | 1.93392657 |
| 123 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.93216029 |
| 124 | Skin nodule (HP:0200036) | 1.92666002 |
| 125 | Blue irides (HP:0000635) | 1.92344652 |
| 126 | Focal seizures (HP:0007359) | 1.91075599 |
| 127 | Progressive neurologic deterioration (HP:0002344) | 1.90324072 |
| 128 | Congenital glaucoma (HP:0001087) | 1.90305306 |
| 129 | Follicular hyperkeratosis (HP:0007502) | 1.89758853 |
| 130 | Polydipsia (HP:0001959) | 1.89330301 |
| 131 | Abnormal drinking behavior (HP:0030082) | 1.89330301 |
| 132 | Partial agenesis of the corpus callosum (HP:0001338) | 1.88124702 |
| 133 | Dysostosis multiplex (HP:0000943) | 1.87938454 |
| 134 | Spastic tetraparesis (HP:0001285) | 1.87716340 |
| 135 | Limb dystonia (HP:0002451) | 1.87460853 |
| 136 | Zonular cataract (HP:0010920) | 1.87242694 |
| 137 | Focal motor seizures (HP:0011153) | 1.86795881 |
| 138 | Morphological abnormality of the inner ear (HP:0011390) | 1.86584633 |
| 139 | Bone cyst (HP:0012062) | 1.86104236 |
| 140 | Renal Fanconi syndrome (HP:0001994) | 1.85033505 |
| 141 | Hypoventilation (HP:0002791) | 1.84947058 |
| 142 | Fetal akinesia sequence (HP:0001989) | 1.84809966 |
| 143 | Hematochezia (HP:0002573) | 1.84474960 |
| 144 | Clonus (HP:0002169) | 1.84074384 |
| 145 | Abnormality of the septum pellucidum (HP:0007375) | 1.83838324 |
| 146 | Absence seizures (HP:0002121) | 1.82654351 |
| 147 | Dialeptic seizures (HP:0011146) | 1.82336426 |
| 148 | Hyperventilation (HP:0002883) | 1.82030145 |
| 149 | Partial duplication of thumb phalanx (HP:0009944) | 1.81572266 |
| 150 | Tongue fasciculations (HP:0001308) | 1.80778699 |
| 151 | Poor speech (HP:0002465) | 1.80470591 |
| 152 | Barrel-shaped chest (HP:0001552) | 1.79808413 |
| 153 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.77819689 |
| 154 | Adrenal hypoplasia (HP:0000835) | 1.77230483 |
| 155 | Vaginal atresia (HP:0000148) | 1.76713803 |
| 156 | Bowel incontinence (HP:0002607) | 1.75939391 |
| 157 | Hypoplasia of the iris (HP:0007676) | 1.75551480 |
| 158 | Generalized myoclonic seizures (HP:0002123) | 1.75532350 |
| 159 | Medial flaring of the eyebrow (HP:0010747) | 1.75312626 |
| 160 | Epileptic encephalopathy (HP:0200134) | 1.74992498 |
| 161 | Axonal loss (HP:0003447) | 1.74576049 |
| 162 | Atonic seizures (HP:0010819) | 1.74547292 |
| 163 | Abnormality of renal resorption (HP:0011038) | 1.73506731 |
| 164 | Hyperlipoproteinemia (HP:0010980) | 1.72713362 |
| 165 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.71871845 |
| 166 | Muscle fiber splitting (HP:0003555) | 1.71068050 |
| 167 | Abnormality of proline metabolism (HP:0010907) | 1.69969907 |
| 168 | Hydroxyprolinuria (HP:0003080) | 1.69969907 |
| 169 | Hypophosphatemic rickets (HP:0004912) | 1.69950069 |
| 170 | Macroorchidism (HP:0000053) | 1.69193465 |
| 171 | Prolonged QT interval (HP:0001657) | 1.68585052 |
| 172 | Decreased motor nerve conduction velocity (HP:0003431) | 1.68382659 |
| 173 | Paraparesis (HP:0002385) | 1.68374164 |
| 174 | Late onset (HP:0003584) | 1.68270087 |
| 175 | Hamartoma of the eye (HP:0010568) | 1.68181946 |
| 176 | Diminished movement (HP:0002374) | 1.67691740 |
| 177 | Neuronal loss in central nervous system (HP:0002529) | 1.67514546 |
| 178 | Relative macrocephaly (HP:0004482) | 1.64024355 |
| 179 | Genital tract atresia (HP:0001827) | 1.63943434 |
| 180 | Abnormality of magnesium homeostasis (HP:0004921) | 1.62604122 |
| 181 | Widely spaced teeth (HP:0000687) | 1.60994271 |
| 182 | Abnormality of the vitreous humor (HP:0004327) | 1.60984905 |
| 183 | Esophageal atresia (HP:0002032) | 1.60940076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.69174707 |
| 2 | FRK | 5.35687965 |
| 3 | OXSR1 | 4.68562378 |
| 4 | WNK4 | 3.26774970 |
| 5 | EPHB1 | 3.23859486 |
| 6 | DAPK2 | 2.69324462 |
| 7 | BCR | 2.60580290 |
| 8 | PRPF4B | 2.50793074 |
| 9 | TNIK | 2.35668161 |
| 10 | WNK1 | 2.35559516 |
| 11 | CDK19 | 2.29511290 |
| 12 | FGFR2 | 2.27805501 |
| 13 | PKN1 | 2.25553081 |
| 14 | MAPKAPK5 | 2.23940958 |
| 15 | MET | 2.20692379 |
| 16 | PBK | 2.09480802 |
| 17 | PINK1 | 1.80732844 |
| 18 | NEK6 | 1.77283779 |
| 19 | PNCK | 1.73976939 |
| 20 | UHMK1 | 1.73480233 |
| 21 | LIMK1 | 1.72706626 |
| 22 | FGFR3 | 1.70990296 |
| 23 | MAP4K2 | 1.70882088 |
| 24 | CSNK1G3 | 1.68216791 |
| 25 | ICK | 1.65962533 |
| 26 | AKT3 | 1.64945214 |
| 27 | CSNK1A1L | 1.64097226 |
| 28 | MAPK15 | 1.61739912 |
| 29 | NTRK1 | 1.58005976 |
| 30 | PAK6 | 1.43525097 |
| 31 | PRKD3 | 1.43042371 |
| 32 | EPHA4 | 1.41746777 |
| 33 | CAMK2B | 1.38982601 |
| 34 | EPHA3 | 1.35211624 |
| 35 | CSNK1G1 | 1.34423471 |
| 36 | MST4 | 1.32755255 |
| 37 | FER | 1.32446841 |
| 38 | ROCK2 | 1.32075727 |
| 39 | CLK1 | 1.30338434 |
| 40 | CSNK1G2 | 1.27639409 |
| 41 | NLK | 1.23043999 |
| 42 | FGR | 1.20839108 |
| 43 | CASK | 1.19776927 |
| 44 | SGK494 | 1.17659052 |
| 45 | SGK223 | 1.17659052 |
| 46 | CAMK2D | 1.17265742 |
| 47 | MAP3K9 | 1.16813939 |
| 48 | MYLK | 1.14917094 |
| 49 | MAP2K6 | 1.14431182 |
| 50 | TESK2 | 1.12986495 |
| 51 | PRKCG | 1.10336255 |
| 52 | PLK2 | 1.08268077 |
| 53 | CAMKK2 | 1.06485027 |
| 54 | STK3 | 0.95516851 |
| 55 | MAP3K4 | 0.93708099 |
| 56 | TYRO3 | 0.90485505 |
| 57 | PAK3 | 0.90480124 |
| 58 | MARK1 | 0.90129154 |
| 59 | PRKCQ | 0.88930897 |
| 60 | CAMK2G | 0.87419732 |
| 61 | CDK5 | 0.86652187 |
| 62 | SGK2 | 0.84473539 |
| 63 | PTK2 | 0.82537809 |
| 64 | CAMK2A | 0.80784069 |
| 65 | CDK14 | 0.78178231 |
| 66 | RIPK1 | 0.75398592 |
| 67 | BMPR1B | 0.75198247 |
| 68 | MARK2 | 0.72981316 |
| 69 | CAMK1 | 0.70529905 |
| 70 | MAP3K12 | 0.70214314 |
| 71 | PDPK1 | 0.69145526 |
| 72 | STK38 | 0.68870006 |
| 73 | TIE1 | 0.68770034 |
| 74 | CDK15 | 0.68303897 |
| 75 | PRKCE | 0.67170830 |
| 76 | ERBB4 | 0.66110542 |
| 77 | ROCK1 | 0.66102548 |
| 78 | CDC42BPA | 0.66021722 |
| 79 | LATS1 | 0.65447341 |
| 80 | DYRK2 | 0.64731055 |
| 81 | PRKD2 | 0.64002970 |
| 82 | CDK18 | 0.63309127 |
| 83 | IRAK2 | 0.63178223 |
| 84 | JAK1 | 0.63136275 |
| 85 | PRKD1 | 0.62734607 |
| 86 | ERBB3 | 0.62358800 |
| 87 | PRKCH | 0.61547429 |
| 88 | SGK3 | 0.60558927 |
| 89 | CDK11A | 0.60450528 |
| 90 | YES1 | 0.60286128 |
| 91 | PDGFRA | 0.59762659 |
| 92 | MINK1 | 0.57099552 |
| 93 | STK38L | 0.56639521 |
| 94 | MUSK | 0.56398231 |
| 95 | PHKG1 | 0.55945218 |
| 96 | PHKG2 | 0.55945218 |
| 97 | TESK1 | 0.55627253 |
| 98 | CAMK1G | 0.55048095 |
| 99 | WNK3 | 0.54519022 |
| 100 | ARAF | 0.52026701 |
| 101 | FYN | 0.51577387 |
| 102 | INSRR | 0.50258617 |
| 103 | PRKG1 | 0.49178068 |
| 104 | ACVR1B | 0.48564290 |
| 105 | CSNK1A1 | 0.48206978 |
| 106 | PRKAA2 | 0.48169480 |
| 107 | PRKAA1 | 0.47465483 |
| 108 | NTRK2 | 0.47378930 |
| 109 | GSK3A | 0.45332599 |
| 110 | STK11 | 0.44537490 |
| 111 | CSNK1D | 0.43216753 |
| 112 | EIF2AK3 | 0.42896655 |
| 113 | PRKCZ | 0.42098976 |
| 114 | RPS6KA5 | 0.39769831 |
| 115 | MAP3K2 | 0.39363020 |
| 116 | KSR2 | 0.39338079 |
| 117 | GRK7 | 0.39077008 |
| 118 | IRAK1 | 0.38859391 |
| 119 | FGFR4 | 0.38805683 |
| 120 | MAP3K13 | 0.38333288 |
| 121 | GRK1 | 0.38023570 |
| 122 | NTRK3 | 0.37741203 |
| 123 | PRKACB | 0.37526165 |
| 124 | PIK3CA | 0.37185039 |
| 125 | TRPM7 | 0.36258337 |
| 126 | ITK | 0.36252343 |
| 127 | PDK1 | 0.36051369 |
| 128 | MELK | 0.34660510 |
| 129 | ADRBK2 | 0.32630034 |
| 130 | INSR | 0.32332180 |
| 131 | MAPK13 | 0.31868408 |
| 132 | MAPK7 | 0.31647148 |
| 133 | MAP2K2 | 0.31460957 |
| 134 | PDGFRB | 0.30718095 |
| 135 | DDR2 | 0.30545653 |
| 136 | PRKACA | 0.30208734 |
| 137 | FES | 0.29917849 |
| 138 | PTK2B | 0.27536282 |
| 139 | BMPR2 | 0.27163355 |
| 140 | HIPK2 | 0.26098638 |
| 141 | MAPK10 | 0.25445874 |
| 142 | SGK1 | 0.24604624 |
| 143 | GRK5 | 0.24262710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.99693926 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.39833880 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.29951215 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.44340950 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.77841282 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65029774 |
| 7 | * Ether lipid metabolism_Homo sapiens_hsa00565 | 2.28942338 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.26965223 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.09019950 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.03499934 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.93173302 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.91286542 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87787715 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.73229705 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.68419705 |
| 16 | Axon guidance_Homo sapiens_hsa04360 | 1.57164301 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.52982159 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47096221 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.43740754 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.39339387 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.37453032 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.35396052 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33978246 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.29834647 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28807458 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.27375489 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27255969 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25624835 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.23844511 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23838280 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23420681 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18658735 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18264921 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.16066429 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.13784423 |
| 36 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13464656 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09617370 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 1.06611236 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05933715 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.03536434 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01112699 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00619608 |
| 43 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00292180 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98339276 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.97699215 |
| 46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96795396 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96133216 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95462475 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95254533 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91164602 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90708286 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89331295 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 0.87699013 |
| 54 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86201422 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85977399 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83350085 |
| 57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.82488595 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.82239890 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 0.81357012 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80222992 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80042647 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79871422 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79557234 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.78791682 |
| 65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.74438155 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74291529 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74203559 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.73384276 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72521291 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72263471 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71491011 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71267441 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71027897 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70921339 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70285119 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69756747 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69658609 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.69321730 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.66692147 |
| 80 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.65782033 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64636938 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64479744 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.64270907 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63064410 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62370399 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62168932 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61483017 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61101361 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61018223 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60594221 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60379777 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60243389 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.60196802 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.59980268 |
| 95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59036292 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54671931 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54416373 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54389060 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54358409 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54155891 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.53210263 |
| 102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51736338 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50929162 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.49615764 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48583490 |
| 106 | Phototransduction_Homo sapiens_hsa04744 | 0.48302176 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46473145 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.46403204 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46349164 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.44215894 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41851219 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40582608 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40542902 |
| 114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40296354 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40240767 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.39379962 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38917070 |
| 118 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38669681 |
| 119 | Gap junction_Homo sapiens_hsa04540 | 0.37631963 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37235176 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.37161595 |
| 122 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37086221 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36983906 |
| 124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36795554 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35842909 |
| 126 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35692760 |
| 127 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.35358012 |
| 128 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34501561 |
| 129 | ABC transporters_Homo sapiens_hsa02010 | 0.32878932 |
| 130 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32301010 |
| 131 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30769356 |

